Literature DB >> 27698871

Analysis of recurrence and survival rates in grade 3 endometrioid endometrial carcinoma.

Jieyu Wang1, Nan Jia1, Qing Li1, Chao Wang1, Xiang Tao2, Keqin Hua3, Weiwei Feng3.   

Abstract

The aim of the present study was to determine risk factors associated with recurrence and survival in patients with grade 3 endometrioid endometrial carcinoma (G3EEC). A retrospective analysis of 117 patients with G3EEC, who were admitted to the Obstetrics and Gynecology Hospital of Fudan University between January 2000 and December 2011, was performed. The χ2 test or Fisher's exact test were used for the comparison of categorical variables. Kaplan-Meier method was used for estimating recurrence-free survival (RFS), disease-specific survival (DSS) and overall survival (OS) rates. Univariate and multivariate Cox proportional hazards model were used to assess the prognostic significance of various patient characteristics. In 117 patients, 16 patients (13.7%) had tumor recurrence, of which 6 (37.5%) developed local-regional recurrence and 10 (62.5%) developed distant recurrence. Out of the 16 patients with tumor recurrence, 14 (87.5%) had a recurrence within 3 years of surgery. Statistically significant characteristics affecting RFS, DSS and OS rates were outer half myometrial invasion (MI ≥50%), advanced International Federation of Gynecology and Obstetrics stage, positive lymph node metastasis (PLNM), lymph vascular space invasion, adnexal involvement and characterization as a high-risk group, according to the Gynecologic Oncology Group 99 stratification algorithm. RFS was associated with the depth of cervical mucosa (stromal) involvement. Furthermore, in the multivariate Cox proportional hazards model, significant independent adverse factors for RFS and DSS included MI ≥50% and adnexal involvement. For OS, there were no statistically significant prognostic factors. In conclusion, MI ≥50% and adnexal involvement are independent prognostic factors for RFS and DSS in G3EEC patients.

Entities:  

Keywords:  adnexal involvement; endometrioid endometrial cancer; grade 3; myometrial invasion; positive lymph nodes metastasis; recurrence; survival

Year:  2016        PMID: 27698871      PMCID: PMC5038389          DOI: 10.3892/ol.2016.4918

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  33 in total

1.  The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.

Authors:  Kaled M Alektiar; Andrea McKee; Oscar Lin; Ennapadam Venkatraman; Michael J Zelefsky; Boris R Mychalczak; Brady McKee; William J Hoskins; Richard R Barakat
Journal:  Cancer       Date:  2002-07-15       Impact factor: 6.860

2.  Nup88 expression is associated with myometrial invasion in endometrial carcinoma.

Authors:  José Schneider; Fernando Martínez-Arribas; Rafael Torrejón
Journal:  Int J Gynecol Cancer       Date:  2010-07       Impact factor: 3.437

3.  Pathological factors associated with omental metastases in endometrial cancer.

Authors:  K Sakai; W Yamagami; N Susumu; H Nomura; F Kataoka; K Banno; H Tsuda; D Aoki
Journal:  Eur J Gynaecol Oncol       Date:  2015       Impact factor: 0.196

4.  Comparison of survival outcomes between patients with malignant mixed mullerian tumors and high-grade endometrioid, clear cell, and papillary serous endometrial cancers.

Authors:  Ashley Sinclair Felix; Roslyn A Stone; Robert Bowser; Mamatha Chivukula; Robert P Edwards; Joel L Weissfeld; Faina Linkov
Journal:  Int J Gynecol Cancer       Date:  2011-07       Impact factor: 3.437

5.  Prognostic significance of gross myometrial invasion with endometrial cancer.

Authors:  D M Larson; G P Connor; S K Broste; B R Krawisz; K K Johnson
Journal:  Obstet Gynecol       Date:  1996-09       Impact factor: 7.661

Review 6.  Recurrent endometrial cancer.

Authors:  Marcela G Del Carmen; David M Boruta; John O Schorge
Journal:  Clin Obstet Gynecol       Date:  2011-06       Impact factor: 2.190

7.  Prospective clinical study of the association between plasma level of free IGF-1 and myometrial invasion min patients with endometrial adenocarcinoma.

Authors:  Ali Baloglu; Incim Bezircioglu; Burcu Cetinkaya; Levent Hicyilmaz
Journal:  Ginekol Pol       Date:  2010-07       Impact factor: 1.232

8.  The significance of the degree of myometrial invasion in patients with stage IB endometrial cancer.

Authors:  O Gemer; L Uriev; T Harkovsky; R Peled; D Ben-Dor; F Barak; S Segal
Journal:  Eur J Gynaecol Oncol       Date:  2004       Impact factor: 0.196

9.  Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

Authors:  C P Morrow; B N Bundy; R J Kurman; W T Creasman; P Heller; H D Homesley; J E Graham
Journal:  Gynecol Oncol       Date:  1991-01       Impact factor: 5.482

10.  Oestrogen receptor beta expression and depth of myometrial invasion in human endometrial cancer.

Authors:  F Takama; T Kanuma; D Wang; I Kagami; H Mizunuma
Journal:  Br J Cancer       Date:  2001-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.